Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel + carboplatin with surgery for locally advanced esophageal squamous cell carcinoma
ChiCTR-TRC-12002037Phase 3Recruiting
- Sponsor
- Shanghai Chest Hospital
- Start
- May 2011
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of paclitaxel and carboplatin in Esophageal Squamous Cell Carcinoma (ESCC) (3 arms), sponsored by Shanghai Chest Hospital. Primary endpoints: Primary tumor size, Metastatic lymph node size and 9 more. Started May 2011; status: recruiting.
02
Drugs
paclitaxelcarboplatin
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on ChiCTR-TRC-12002037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002037.